Treatment of Keratoacanthomas With Intralesional Fluorouracil

Intralesional chemotherapy for nonmelanoma skin cancer: A practical review

“…The one tumor that did not respond was reported by Odom and Goette. 16 The KA was located on the earlobe and did not involute after 5 treatments; subsequent excision removed the tumor and confirmed the diagnosis of KA. Posttreatment biopsies were done in 4 patients.…”

“…[11][12][13][14][15][16][17][18][19] Three articles reported the use of 5FU in 23 BCCs. 12,20,21 Table II summarizes the data from these 12 studies.…”

“…Posttreatment biopsies were done in 4 patients. [16][17][18] Some cases have been followed up for as long as 24 months or more without recurrence. 12 Laboratory testing (Table V) was done in 6 patients without any abnormal finding.…”

“…12 Laboratory testing (Table V) was done in 6 patients without any abnormal finding. 13,16 Three articles reported the use of 5FU in 23 BCCs. One tumor was excluded because topical 5FU was used immediately before intralesional use for a BCC.…”

Self-Healing Epitheliomata of Ferguson-Smith: Cytogenetic and Histological Studies, and the Therapeutic Effect of Etretinate

“…A trial of 5-fluorouracil treatment was initiated following a report of its successful use in keratoacanthomas [10]. Intralesional injections of up to 0.3 ml of 50 mg/ml solu tion were used for lesions up to 5 mm in di ameter and repeated at weekly intervals for 6 weeks.…”